Company news
Connect Biopharma Holdings Limited news in 2021
Connect Biopharma Holdings Limited's news releases, calls and decks from 2021, newest first.
Connect Biopharma Expands Executive Leadership Team with Hire of Chief Financial Officer
November 21, 2021
Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2 Clinical Trial in Moderate-to-Severe Ulcerative Colitis
November 18, 2021
Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis
November 17, 2021
Connect Biopharma Announces First Subject Dosed in Phase 2 Trial Evaluating CBP-201 in Adult Patients with Chronic Rhinosinusitis with Nasal Polyps
September 7, 2021
Connect Biopharma Announces First Patient Dosed in China Pivotal Trial Evaluating CBP-201 in Adults with Moderate-to-Severe Atopic Dermatitis
September 1, 2021
Connect Biopharma Provides Business Update and Reports First Half 2021 Financial Results
August 30, 2021
Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member
August 22, 2021
Connect Biopharma Announces First Subject Dosed in Phase I Trial Evaluating Safety, Tolerability and Pharmacokinetic Profile of CBP-174 in Healthy Adult Subjects
May 24, 2021
Connect Biopharma Announces First Patient Dosed in Phase 2 Trial Evaluating CBP-201 in Adults with Moderate-to-Severe Persistent Asthma
May 11, 2021
Connect Biopharma Completes Enrollment of CBP-201 Global Phase 2 Clinical Trial in Moderate-to-Severe Atopic Dermatitis
April 7, 2021
Connect Biopharma Holdings Limited Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares
March 22, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (June 2021)
Investor deck · 31 slides · Jun 3, 2021